140 related articles for article (PubMed ID: 8531335)
1. [Neutropenia in patient with X-linked hyper-IgM syndrome].
Iwata M; Nunoi H; Nonoyama S; Shimadzu M; Higuchi S; Yanabe Y; Migita M; Adachi N; Matsuda I
Rinsho Ketsueki; 1995 Oct; 36(10):1223-9. PubMed ID: 8531335
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
3. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
Kroczek RA; Graf D; Brugnoni D; Giliani S; Korthüer U; Ugazio A; Senger G; Mages HW; Villa A; Notarangelo LD
Immunol Rev; 1994 Apr; 138():39-59. PubMed ID: 7915248
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.
Wang WC; Cordoba J; Infante AJ; Conley ME
Am J Pediatr Hematol Oncol; 1994 May; 16(2):160-3. PubMed ID: 7513136
[TBL] [Abstract][Full Text] [Related]
7. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
Bhushan A; Covey LR
Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
[TBL] [Abstract][Full Text] [Related]
8. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
[TBL] [Abstract][Full Text] [Related]
9. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
Lougaris V; Badolato R; Ferrari S; Plebani A
Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
[TBL] [Abstract][Full Text] [Related]
10. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
11. An evolving view of hyper-IgM syndrome.
Conley ME
J Pediatr; 1997 Jul; 131(1 Pt 1):8-9. PubMed ID: 9255183
[No Abstract] [Full Text] [Related]
12. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
[TBL] [Abstract][Full Text] [Related]
13. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
14. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
Thomas C; de Saint Basile G; Le Deist F; Theophile D; Benkerrou M; Haddad E; Blanche S; Fischer A
N Engl J Med; 1995 Aug; 333(7):426-9. PubMed ID: 7542361
[No Abstract] [Full Text] [Related]
15. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
Atarod L; Aghamohammadi A; Moin M; Kanegane H; Rezaei N; Rezaei Kalantari K; Amirzagar AA; Futatani T; Miyawaki M
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):37-40. PubMed ID: 17303928
[TBL] [Abstract][Full Text] [Related]
16. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
17. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia.
Mori M; Nonoyama S; Neubauer M; Mitsuda T; Kosuge K; Yokota S
J Pediatr Hematol Oncol; 2000; 22(3):288-9. PubMed ID: 10864066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
